GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 63 filers reported holding GAMIDA CELL LTD in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $750,501 | -46.6% | 728,642 | +0.1% | 0.00% | -50.0% |
| Q2 2023 | $1,404,661 | +240013.0% | 728,083 | +0.7% | 0.00% | +100.0% |
| Q1 2023 | $585 | -37.1% | 722,792 | +0.3% | 0.00% | -33.3% |
| Q4 2022 | $930 | -99.9% | 720,913 | +0.7% | 0.00% | -40.0% |
| Q3 2022 | $1,138,000 | -7.9% | 715,795 | +2.6% | 0.01% | 0.0% |
| Q2 2022 | $1,235,000 | -52.1% | 697,534 | +12.3% | 0.01% | -50.0% |
| Q1 2022 | $2,579,000 | +77.0% | 621,334 | +8.3% | 0.01% | +66.7% |
| Q4 2021 | $1,457,000 | -20.0% | 573,747 | +23.5% | 0.01% | -40.0% |
| Q3 2021 | $1,821,000 | -21.3% | 464,447 | +28.7% | 0.01% | -28.6% |
| Q2 2021 | $2,313,000 | +43.0% | 360,781 | +80.4% | 0.01% | +27.3% |
| Q1 2021 | $1,618,000 | +248.7% | 200,000 | +78.9% | 0.01% | +175.0% |
| Q3 2020 | $464,000 | – | 111,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $9,985,000 | 2.25% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 175,000 | $721,000 | 0.56% |
| Rock Springs Capital Management LP | 2,154,300 | $8,940,000 | 0.22% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $2,195,000 | 0.20% |
| Platform Technology Partners | 55,625 | $231,000 | 0.11% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,000,000 | $4,150,000 | 0.10% |
| Guild Investment Management, Inc. | 18,000 | $75,000 | 0.08% |
| FEDERATED HERMES, INC. | 5,128,300 | $21,282,000 | 0.05% |
| MEITAV INVESTMENT HOUSE LTD | 429,352 | $1,782,000 | 0.03% |
| 1492 Capital Management LLC | 10,000 | $42,000 | 0.02% |